Taken together, these data reveal a largely distinct co-alteration landscape between KRAS and EGFR-altered non-Sq NSCLC across ancestry groups and multiple overlapping as well as ancestry-specific co-occurring and mutually exclusive alterations within KRAS- and EGFR-altered non-Sq NSCLC. This evidence concerns the gene KRAS and non-small cell lung carcinoma.